| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3032016 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2016 | 7 Pages |
IntroductionGenetic variation in the clusterin gene has been associated with Alzheimer Disease (AD), and the clusterin protein is thought to play a mechanistic role. We explored the associations of clusterin plasma levels with incident dementia, AD, and stroke.MethodsPlasma clusterin was assessed in 1532 nondemented participants from the Framingham Study Offspring cohort between 1998 and 2001 (mean age, 69 ± 6; 53% women). We related clusterin levels to risk of incident dementia, AD, and stroke using Cox-proportional hazards models and examined potential interactions.ResultsA significant interaction of plasma clusterin levels with age was observed. Clusterin was significantly associated with increased risk of dementia among elderly persons (>80 years; hazard ratio [HR], 95% confidence interval = 6.25, 1.64–23.89; P = .007) and with decreased risk of dementia (HR = 0.53, 0.32–0.88; P = .013) and stroke (HR = 0.78, 0.63–0.97; P = .029) among younger participants.DiscussionThe association between plasma clusterin levels and risk of dementia and stroke may be modified by age or an age-related factor.
